TECNIS Synergy – Toric II PC-IOLS Available Now In North America For Cataract Patients
June 25, 2021

TECNIS Synergy – Toric II PC-IOLS Available Now In North America For Cataract Patients

Johnson & Johnson Vision Brings TECNIS Synergy And TECNIS Synergy Toric II PC-IOLS To North America For Cataract Patients

The next-generation presbyopia-correcting intraocular lens (PC-IOL)offers cataract patients the widest range of continuous vision and best near vision among leading PC-IOLs.

Now available in the U.S. and Canada, TECNIS Synergy PC-IOLs offers cataract patients the opportunity to experience excellent outcomes, with 9 out of 10 patients surveyed reporting they didn’t wear glasses following treatment.

Throughout Cataract Awareness Month in June, Johnson & Johnson Vision is providing education about the symptoms of cataracts and the many treatments options available.

Johnson & Johnson Vision, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies, recently announced the availability of TECNIS Synergy and TECNIS Synergy Toric II IOLs in the United States and Canada.

These next-generation PC-IOLs combine the best of extended depth of focus and multifocal technologies to deliver the widest range of continuous vision and the best near vision among leading PC-IOLs,without the visual gaps seen with some existing multifocal technologies.

Ophthalmologists across North America are now able to use this breakthrough PC-IOL to help treat their cataract patients, offering them the opportunity to experience excellent outcomes.

Cataracts are the leading cause of preventable blindness worldwide, impacting more than 100 million eyes, with more than 90% of people developing cataracts by the age of 65. 

Most people will develop cataracts at some point in their life, and modern cataract surgery is a safe and effective treatment that has a success rate of nearly 98%. 

However, in the U.S., 22% of people with cataracts say that their lack of knowledge of the procedure is a barrier to them seeking treatment, with many not realizing that there are intraocular lenses (IOL) available that may give them freedom from glasses.

Today’s 55 – 64-year-olds are also using digital devices at much higher rates, and there’s been a rapid increase in adoption of LED lighting, requiring an IOL that delivers high-quality vision, at all distances, in all lighting conditions.

“My cataract patients are getting younger, have more active lifestyles, and want to be able to see their smartphones in the day and their menus at dinner,” said Dr. Vance Thompson, Vance Thompson Vision in Sioux Falls, South Dakota. 

“They have high expectations for their vision following cataract surgery, and the patients I’ve implanted with TECNIS Synergy™ IOL have not been let down. This new lens has provided the wide range of continuous vision patients are looking for, with great image contrast throughout the day, even in low lighting conditions.”

“I’ve been using the TECNIS Synergy IOL for the past year and have been extremely impressed with the wide range of continuous vision it provides,” said Dr. Sheldon Herzig, Herzig Eye Institute in Toronto and Ottawa. 

“This lens has provided the best near vision for my patients, and most of my patients have said they have not used their glasses following surgery.I implanted my first TECNIS Synergy Toric II last week, which also corrects my patients’ astigmatism to improve both distance and near vision.”

The TECNIS Synergy IOL is built on the legacy TECNIS platform and delivers excellent performance, image contrast, and patient outcomes: 

  • Widest range of continuous vision among leading PC-IOLs — 93% of patients achieved 20/25 or better binocular distance-corrected visual acuity.
  • Best nearvision — patients gained an additional line of visual acuity at near distances versus a leading PC-IOL.
  • Superior image contrast — achieved two times better image contrast in low lighting conditions compared to IOLs of comparable range.
  • High satisfaction with nighttime activities — 97% of patients were able see steps or curbs, 96% were able to see a menu in a dimly lit restaurant, and 90% were able to see objects and read street signs.
  • Reduced need for glasses — 9 out of 10 patients studied didn’t wear glasses after surgery.

“Around the world, the excitement for TECNIS Synergy PC-IOLs has been incredible and we’re proud of the excellent outcomes this innovation has delivered for patients,” said Sandor Palfi, Commercial Vice President of the Americas, Surgical at Johnson & Johnson Vision. 

“We are delighted to bring the most advanced TECNIS IOL to North America with TECNIS Synergy. Surgeons across the U.S. and Canada now have access to an IOL that will meet the needs of today’s cataract patients, who don’t want their life or their vision to be limited by their IOL.”

The TECNIS Synergy PC-IOL was first launched in Europe and Asia Pacific in 2019 and is now available in Latin America, Canada, and the United States.

Ophthalmologists in North America can learn more about the TECNIS Synergy PC-IOL portfolio at the Annual Canadian Ophthalmological Society virtual meeting later this week, and at the American Society of Cataract & Refractive Surgeons Annual Meeting in Las Vegas in July. 

In addition to bringing the full TECNIS Synergy PC-IOL portfolio to the market in North America this month, Johnson & Johnson Vision is providing education to patients and caregivers about the symptoms of cataracts and the treatments options.

In honor of Cataract Awareness Month, Johnson & Johnson is sharing cataract patient stories and information from ophthalmologist through various media, digital, and social media channels.